{
    "2018-12-13": [
        [
            {
                "time": "2018-01-02",
                "original_text": "A Closer Look at Biogenâ€™s Gross Margin Trends",
                "features": {
                    "keywords": [
                        "Biogen",
                        "gross margin",
                        "trends"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?",
                "features": {
                    "keywords": [
                        "Franklin LibertyQ",
                        "ETF",
                        "FLQL",
                        "strong"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Stocks - Ciena Jumps in Premarket, Apple Gains, Tailored Brands Crashes",
                "features": {
                    "keywords": [
                        "Ciena",
                        "Apple",
                        "Tailored Brands",
                        "premarket",
                        "jumps",
                        "gains",
                        "crashes"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "retail"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug",
                "features": {
                    "keywords": [
                        "Lilly",
                        "AC Immune",
                        "Alzheimer's",
                        "drug",
                        "deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly and Co.",
                "features": {
                    "keywords": [
                        "IHS Markit",
                        "score",
                        "Eli Lilly",
                        "report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)",
                "features": {
                    "keywords": [
                        "FDA",
                        "Fast Track",
                        "Baricitinib",
                        "SLE",
                        "development"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease",
                "features": {
                    "keywords": [
                        "Boehringer Ingelheim",
                        "Lilly",
                        "Duke Clinical Research Institute",
                        "Type 2 Diabetes",
                        "Cardiovascular Disease",
                        "partnership"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Eli Lilly: FDA Grants Fast Track Designation To Baricitinib Development Program",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA",
                        "Fast Track",
                        "Baricitinib",
                        "development"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}